Arcturus Therapeutics Holdings Inc (ARCT)
27.93
+0.87
(+3.22%)
USD |
NASDAQ |
Apr 23, 16:00
27.93
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Shareholders Equity (Quarterly): 278.51M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 278.51M |
| September 30, 2023 | 280.06M |
| June 30, 2023 | 285.18M |
| March 31, 2023 | 329.25M |
| December 31, 2022 | 270.31M |
| September 30, 2022 | 145.67M |
| June 30, 2022 | 170.72M |
| March 31, 2022 | 184.75M |
| December 31, 2021 | 228.21M |
| September 30, 2021 | 259.13M |
| June 30, 2021 | 305.65M |
| March 31, 2021 | 352.61M |
| December 31, 2020 | 396.55M |
| September 30, 2020 | 261.63M |
| June 30, 2020 | 93.42M |
| March 31, 2020 | 16.98M |
| December 31, 2019 | 25.79M |
| September 30, 2019 | 35.90M |
| June 30, 2019 | 21.62M |
| March 31, 2019 | 6.354M |
| December 31, 2018 | 13.64M |
| Date | Value |
|---|---|
| September 30, 2018 | 14.15M |
| June 30, 2018 | 17.80M |
| December 31, 2017 | 33.79M |
| September 30, 2017 | 38.29M |
| June 30, 2017 | 40.69M |
| March 31, 2017 | 44.23M |
| December 31, 2016 | 1.577M |
| September 30, 2016 | 52.62M |
| June 30, 2016 | 59.78M |
| March 31, 2016 | 64.99M |
| December 31, 2015 | 69.33M |
| September 30, 2015 | 35.08M |
| June 30, 2015 | 38.76M |
| December 31, 2014 | 19.94M |
| September 30, 2014 | 25.96M |
| June 30, 2014 | 35.42M |
| March 31, 2014 | 42.26M |
| December 31, 2013 | 48.69M |
| September 30, 2013 | 18.52M |
| June 30, 2013 | 21.36M |
| December 31, 2012 | -0.567M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.98M
Minimum
Mar 2020
396.55M
Maximum
Dec 2020
207.47M
Average
259.13M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.23M |
| Perspective Therapeutics Inc | 75.18M |
| Protalix BioTherapeutics Inc | 33.57M |
| Electromed Inc | 40.34M |
| Armata Pharmaceuticals Inc | -32.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 429.40M |
| Total Liabilities (Quarterly) | 150.89M |
| Current Ratio | 4.715 |
| Net Debt Paydown Yield | 1.41% |